{"title":"血液病特刊编者注","authors":"Karthik Bommannan","doi":"10.1055/s-0043-1772237","DOIUrl":null,"url":null,"abstract":"The field of hematopathology is rapidly evolving. Along with advancements in the fields of flow cytometry and molecular diagnostics, the assessment of minimal residual disease (MRD) has progressively become a cornerstone in the clinical management of hematologic malignancies. The idea to have a special issue on hematopathology in the Indian Journal of Medical and Pediatric Oncology (IJMPO) was conceptualized by Dr. Padmaj S. Kulkarni (Editor-in-Chief at that time) and was further materialized under the current Editor-in-chief Dr. Seema Gulia. I feel honored to have been given an opportunity to be the Editor for this special issue in my field of interest and expertise.","PeriodicalId":13513,"journal":{"name":"Indian Journal of Medical and Paediatric Oncology","volume":"21 1","pages":"0"},"PeriodicalIF":0.3000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Editor's Note on Hematopathology Special Issue\",\"authors\":\"Karthik Bommannan\",\"doi\":\"10.1055/s-0043-1772237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The field of hematopathology is rapidly evolving. Along with advancements in the fields of flow cytometry and molecular diagnostics, the assessment of minimal residual disease (MRD) has progressively become a cornerstone in the clinical management of hematologic malignancies. The idea to have a special issue on hematopathology in the Indian Journal of Medical and Pediatric Oncology (IJMPO) was conceptualized by Dr. Padmaj S. Kulkarni (Editor-in-Chief at that time) and was further materialized under the current Editor-in-chief Dr. Seema Gulia. I feel honored to have been given an opportunity to be the Editor for this special issue in my field of interest and expertise.\",\"PeriodicalId\":13513,\"journal\":{\"name\":\"Indian Journal of Medical and Paediatric Oncology\",\"volume\":\"21 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Medical and Paediatric Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1772237\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Medical and Paediatric Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1772237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
血液病理学领域正在迅速发展。随着流式细胞术和分子诊断技术的进步,微小残留病(MRD)的评估已逐渐成为血液系统恶性肿瘤临床管理的基石。在《印度医学和儿科肿瘤学杂志》(IJMPO)上发表关于血液病理学的特刊的想法是由Padmaj S. Kulkarni博士(当时的主编)提出的,并在现任主编Seema Gulia博士的领导下进一步具体化。我很荣幸有机会在我感兴趣和专业的领域担任本期特刊的编辑。
The field of hematopathology is rapidly evolving. Along with advancements in the fields of flow cytometry and molecular diagnostics, the assessment of minimal residual disease (MRD) has progressively become a cornerstone in the clinical management of hematologic malignancies. The idea to have a special issue on hematopathology in the Indian Journal of Medical and Pediatric Oncology (IJMPO) was conceptualized by Dr. Padmaj S. Kulkarni (Editor-in-Chief at that time) and was further materialized under the current Editor-in-chief Dr. Seema Gulia. I feel honored to have been given an opportunity to be the Editor for this special issue in my field of interest and expertise.
期刊介绍:
The journal will cover technical and clinical studies related to medical and pediatric oncology in human well being including ethical and social issues. Articles with clinical interest and implications will be given preference.